Preferred Label : piribedil;
MeSH definition : A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly
for alleviation of tremor. It has also been used for circulatory disorders and in
other applications as a D2 agonist.;
MeSH synonym : piribendyl;
MeSH hyponym : ET-495; EU-4200; piribedil hydrochloride; Piribedil Mesylate; trivastal; piribedil mono-hydrochloride; EU 4200; EU4200; Mesylate, Piribedil; Mono-hydrochloride, Piribedil; Piribedil Mono hydrochloride; ET 495; ET495; Hydrochloride, Piribedil;
MeSH CAS label : pyrimidine, 2-(4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl)-;
MeSH Related Number : piribedil mesylate; piribedil mono-hydrochloride; piribedil hydrochloride; 3605-01-4 (Piribedil); 52293-23-9 (mesylate); 69239-66-3 (HCl); 78213-63-5 (mono-HCl);
Registry Number MeSH : 3605-01-4;
Related CAS MeSH : 52293-23-9 (Piribedil mesylate); 78213-63-5 (Piribedil mono-hydrochloride); 69239-66-3 (Piribedil hydrochloride);
Wikipedia link : https://en.wikipedia.org/wiki/Piribedil;
Codes EINECS : 222-764-6;
Is substance : O;
UNII : DO22K1PRDJ;
InChIKey : OQDPVLVUJFGPGQ-UHFFFAOYSA-N;
Origin ID : D010891;
UMLS CUI : C0031979;
ATC code(s)
ATC code(s)
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
Manual BTNT mappings - CISMeF
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly
for alleviation of tremor. It has also been used for circulatory disorders and in
other applications as a D2 agonist.
https://www.has-sante.fr/jcms/p_3320593/fr/trivastal-piribedil
2022
false
false
false
France
insurance, health, reimbursement
administration, oral
piribedil
evaluation of the transparency committee
piribedil
---
https://www.has-sante.fr/portail/jcms/c_2803489/fr/trivastal
2017
false
false
false
France
French
evaluation of the transparency committee
trivastal
piribedil
---
http://www.has-sante.fr/portail/jcms/c_1361966/trivastal
http://www.has-sante.fr/portail/upload/docs/evamed/CT-12441_TRIVASTAL_RI_avis2_CT12441.pdf
http://www.has-sante.fr/portail/jcms/c_619586/trivastal
http://www.has-sante.fr/portail/jcms/c_400083/trivastal-20-mg-50mg-lp-comprime-enrobe-boite-de-30
2013
false
France
French
evaluation of the transparency committee
administration, oral
insurance, health, reimbursement
piribedil
piribedil
Delayed-Action preparations
drug therapy, combination
parkinson disease
antiparkinson agents
dopamine agonists
risk assessment
dopamine agonists
antiparkinson agents
product surveillance, postmarketing
---